Major Price Drop Announced for Bedaquiline, a Vital Drug in TB Treatment

NewsLeave a comment

In a significant development, the Stop TB Partnership’s Global Drug Facility (GDF) has declared substantial price reductions of up to 55% for bedaquiline, a crucial drug used in treating drug-resistant TB (DR-TB). The revised bedaquiline prices, obtained through an open and competitive tender, will be in effect until December 2024, benefiting the majority of low-…

Largest genetic study of epilepsy to date provides new insights on why epilepsy develops and potential treatments

Press ReleaseLeave a comment

The largest genetic study of its kind, coordinated by the International League Against Epilepsy, including scientists from FutureNeuro at RCSI University of Medicine and Health Sciences, has discovered specific changes in our DNA that increase the risk of developing epilepsy.  The research, published in Nature Genetics, greatly advances our knowledge of why epilepsy develops and…